Aspirin protects the heart by preventing blood clots from forming inside your arteries. It does this permanently disabling a key enzyme in platelets, the tiny blood cells responsible for clotting. This simple mechanism has made aspirin one of the most widely used cardiovascular medications in the world, but the guidelines on who should take it have shifted significantly in recent years.
How Aspirin Prevents Blood Clots
Your platelets contain an enzyme that produces a chemical signal telling other platelets to clump together. Aspirin permanently shuts down that enzyme by chemically altering its structure. Once a platelet has been exposed to aspirin, it can never produce that clumping signal again for the rest of its lifespan, which is about 7 to 10 days. This is why even a small daily dose has a lasting effect: each day’s pill disables a fresh batch of platelets before they get a chance to form dangerous clots.
Blood clots inside arteries are what cause most heart attacks and many strokes. A clot typically forms when a fatty plaque inside an artery wall cracks or ruptures. Platelets rush to the site and pile on top of each other, potentially blocking blood flow entirely. By keeping platelets less “sticky,” aspirin reduces the chance that a small plaque rupture turns into a full blockage.
Benefits for People With Existing Heart Disease
Aspirin’s strongest proven benefit is in people who have already had a heart attack, stroke, or other cardiovascular event. This is called secondary prevention, and decades of research back it up. A landmark analysis combining data from 25 trials and roughly 29,000 patients found that aspirin reduced the risk of dying from a vascular cause by 15%. A follow-up analysis of 20,000 patients with a prior heart attack showed an absolute 4% reduction in major vascular events over just two years.
Those numbers may sound modest in percentage terms, but across large populations they translate to thousands of prevented heart attacks and deaths. For someone who has already had a cardiac event, the benefit of daily low-dose aspirin consistently outweighs the bleeding risk, which is why it remains a standard part of treatment after a heart attack, stent placement, or bypass surgery.
Why Guidelines Changed for Healthy Adults
For people who have never had a heart attack or stroke, the picture looks very different. In October 2021, the U.S. Preventive Services Task Force updated its recommendations with two key points: low-dose aspirin should not be started for heart disease prevention in adults 60 or older, and adults aged 40 to 59 with at least a 10% chance of a cardiovascular event in the next decade should discuss it with their doctor on a case-by-case basis.
The reason for this shift is that modern treatments for high blood pressure, high cholesterol, and diabetes have gotten much better. Statins, blood pressure medications, and lifestyle changes now prevent many of the heart attacks that aspirin used to prevent, so the added benefit of aspirin for a healthy person has shrunk. Meanwhile, the bleeding risk hasn’t changed. For most people without established heart disease, the math no longer works in aspirin’s favor.
The Bleeding Risk
Aspirin’s ability to prevent clotting is also its main downside. The same mechanism that stops dangerous clots inside arteries also interferes with the helpful clotting your body needs when, say, your stomach lining develops a small ulcer. In primary prevention studies, low-dose aspirin (100 mg or less per day) increased the risk of major gastrointestinal bleeding by 58%. It also raised hemorrhagic stroke risk by about 27%, though that increase was not statistically definitive.
In practical terms, the extra bleeding risk works out to roughly 1 to 2 additional major gastrointestinal bleeds per 1,000 people per year of aspirin use. For someone at low baseline risk, the number drops to about 1 extra bleed per 10,000 people per year. The risk climbs with age, a history of stomach ulcers, regular alcohol use, or taking other blood-thinning medications. This is the core of the risk-benefit calculation: for people who already have heart disease, the prevented heart attacks far outnumber the extra bleeds. For healthy people, the two risks are much closer to equal.
Standard Dosing
The dose used for heart protection is much lower than what you’d take for a headache. In the U.S., the standard low-dose aspirin tablet is 81 mg, sometimes called “baby aspirin.” In the U.K. and much of Europe, the standard heart-protection dose is 75 mg. Both are far below the 300 to 650 mg doses used for pain relief. This low dose is enough to disable the vast majority of platelets without suppressing other protective functions throughout the body as aggressively.
Chewing Aspirin During a Heart Attack
If you or someone nearby is having symptoms of a heart attack, chewing a regular aspirin (not swallowing it whole) is one of the most important things you can do while waiting for emergency services. Chewing breaks the tablet into smaller fragments that dissolve and absorb through the lining of your mouth and stomach much faster than a whole tablet sitting in your gut. This gets aspirin into your bloodstream within minutes rather than the 20 to 30 minutes a swallowed pill can take. It slows blood clotting at the site of the blocked artery and can reduce the severity of heart muscle damage before paramedics arrive.
When Aspirin Doesn’t Work as Expected
Not everyone responds to aspirin equally. Research estimates that roughly 20 to 30% of patients with vascular disease show signs of aspirin resistance, meaning their platelets remain active despite regular aspirin use. Some studies have found resistance rates as high as 60% in certain populations. This isn’t just a lab curiosity: aspirin-resistant patients face nearly a three-fold higher rate of major cardiovascular events compared to those whose platelets respond normally. One analysis found that resistant patients had up to six times the mortality risk.
The causes of aspirin resistance are varied. Some people absorb the drug poorly, some have genetic differences in their platelet enzymes, and some have conditions like diabetes or obesity that drive platelet activity through alternate pathways aspirin doesn’t block. There is currently no routine test offered to most patients to check whether their aspirin is actually working, though point-of-care testing is an active area of clinical interest. If you’re taking aspirin for heart protection and continue to have cardiovascular events, this is something worth raising with your cardiologist.